Riluzole Oral Suspension — FDA Drug Shortage
The FDA lists a drug shortage record for Riluzole Oral Suspension (oral suspension) from EDW Pharma, Inc. (Formerly Italfarmaco Pharma, Inc.) with status Current. The shortage was first posted on Jan 26, 2024. Reported reason: Requirements related to complying with good manufacturing practices
Shortage details
- Status
- Current
- Company
- EDW Pharma, Inc. (Formerly Italfarmaco Pharma, Inc.)
- Package NDC
- 70726-0303-1
- Dosage Form
- Oral Suspension
- Presentation
- Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)
- Initial Posting
- Jan 26, 2024
Reason
Requirements related to complying with good manufacturing practices